China Pharma Holdings (CPHI) Change in Receivables (2010 - 2026)
China Pharma Holdings (CPHI) posted Change in Receivables of $151,378 for Q2 2026, up 636.1% from $20,566 a year earlier and up 979.8% from the prior quarter.
China Pharma Holdings (CPHI) Change in Receivables (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Receivables at China Pharma Holdings was -$13.23 million; for FY2025, it came in at -$13.21 million.
- In prior years, China Pharma Holdings' Change in Receivables was $197,708 in FY2024 (-78.9%), $938,021 in FY2023 (+451.1%), $170,194 in FY2022 (-68.8%) and $545,534 in FY2021 (-11.1%).
- The Q2 2026 figure stands as the highest quarterly Change in Receivables since Q1 2025.
- On a year-over-year basis, Change in Receivables increased in 1 of the last five quarters, with growth averaging 89.2%.
- The strongest year-over-year quarter for Change in Receivables in the past five years was Q2 2026, with growth of 636.1%; the weakest was Q1 2026, with a decline of 91.5%.
- According to Business Quant data, Change in Receivables for the three prior quarters was $14,019 (Q1 2026), -$13.51 million (Q4 2025) and $117,491 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 140.20 Mn |
| 10 | China Pharma Holdings | 29.58 Mn | 28.46 Mn | 83,566.00 | 151,378.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 151,378.00 |
| Mar 31, 2026 | 14,019.00 |
| Dec 31, 2025 | -13.51 Mn |
| Sep 30, 2025 | 117,491.00 |
| Jun 30, 2025 | 20,566.00 |
| Mar 31, 2025 | 164,670.00 |
| Dec 31, 2024 | 212,942.00 |
| Sep 30, 2024 | 167,299.00 |
| Jun 30, 2024 | -62,163.00 |
| Mar 31, 2024 | -120,370.00 |
| Dec 31, 2023 | 364,258.00 |
| Sep 30, 2023 | 229,314.00 |
| Jun 30, 2023 | -89,857.00 |
| Mar 31, 2023 | 434,306.00 |
| Dec 31, 2022 | 107,286.00 |
| Sep 30, 2022 | 211,013.00 |
| Jun 30, 2022 | 110,025.00 |
| Mar 31, 2022 | -258,130.00 |
| Dec 31, 2021 | 393,662.00 |
| Sep 30, 2021 | 31,115.00 |
China Pharma Holdings Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=CPHI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();